Skip to main navigation Skip to search Skip to main content

Evaluation of Ochrobactrum intermedium bacteremia in a patient with bladder cancer

  • Faculty of Medicine, Thammasat University
  • St. Louis University School of Public Health
  • Philadelphia FIGHT

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Abstract

It is generally believed that Ochrobactrum anthropi is the only pathogenic species in the genus Ochrobactrum. We report a case of presumptive Ochrobactrum intermedium bacteremia in a patient with bladder cancer. Identification of a rare species using rapid commercial panel could lead to an erroneous result as this clinical isolate was initially reported to be Shewanella putrefaciens. The patient was successfully treated with imipenem and ciprofloxacin.

Original languageEnglish
Pages (from-to)153-155
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume53
Issue number2
DOIs
Publication statusPublished - Oct 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bacteremia
  • Bladder cancer
  • Gastrointestinal tract colonization
  • Immunocompromised
  • Ochrobactrum anthropi
  • Ochrobactrum intermedium
  • Shewanella putrefaciens

Fingerprint

Dive into the research topics of 'Evaluation of Ochrobactrum intermedium bacteremia in a patient with bladder cancer'. Together they form a unique fingerprint.

Cite this